ID   PLMN_RAT                Reviewed;         812 AA.
AC   Q01177; Q5BKB6; Q9R0W3;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   31-AUG-2004, sequence version 2.
DT   02-OCT-2024, entry version 190.
DE   RecName: Full=Plasminogen;
DE            EC=3.4.21.7;
DE   Contains:
DE     RecName: Full=Plasmin heavy chain A;
DE   Contains:
DE     RecName: Full=Activation peptide;
DE   Contains:
DE     RecName: Full=Angiostatin;
DE   Contains:
DE     RecName: Full=Plasmin heavy chain A, short form;
DE   Contains:
DE     RecName: Full=Plasmin light chain B;
DE   Flags: Precursor;
GN   Name=Plg;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RA   Bangert K., Johnsen A.H., Thorsen S.;
RT   "Rat plasminogen: cDNA and gene structure.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 343-511.
RC   TISSUE=Liver;
RX   PubMed=1645711; DOI=10.1016/s0021-9258(18)99093-9;
RA   Kanalas J.J., Makker S.P.;
RT   "Identification of the rat Heymann nephritis autoantigen (GP330) as a
RT   receptor site for plasminogen.";
RL   J. Biol. Chem. 266:10825-10829(1991).
CC   -!- FUNCTION: Plasmin dissolves the fibrin of blood clots and acts as a
CC       proteolytic factor in a variety of other processes including embryonic
CC       development, tissue remodeling, tumor invasion, and inflammation. In
CC       ovulation, weakens the walls of the Graafian follicle. It activates the
CC       urokinase-type plasminogen activator, collagenases and several
CC       complement zymogens, such as C1 and C5. Cleavage of fibronectin and
CC       laminin leads to cell detachment and apoptosis. Also cleaves fibrin,
CC       thrombospondin and von Willebrand factor. Its role in tissue remodeling
CC       and tumor invasion may be modulated by CSPG4. Binds to cells (By
CC       similarity). {ECO:0000250}.
CC   -!- FUNCTION: Angiostatin is an angiogenesis inhibitor that blocks
CC       neovascularization and growth of experimental primary and metastatic
CC       tumors in vivo. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Preferential cleavage: Lys-|-Xaa > Arg-|-Xaa, higher
CC         selectivity than trypsin. Converts fibrin into soluble products.;
CC         EC=3.4.21.7;
CC   -!- ACTIVITY REGULATION: Converted into plasmin by plasminogen activators,
CC       both plasminogen and its activator being bound to fibrin. Cannot be
CC       activated with streptokinase.
CC   -!- SUBUNIT: Interacts (both mature PLG and the angiostatin peptide) with
CC       AMOT and CSPG4. Interacts (via the Kringle domains) with HRG; the
CC       interaction tethers PLG to the cell surface and enhances its
CC       activation. Interacts (via Kringle 4 domain) with ADA; the interaction
CC       stimulates PLG activation when in complex with DPP4. Angiostatin:
CC       Interacts with ATP5F1A; the interaction inhibits most of the angiogenic
CC       effects of angiostatin. {ECO:0000250|UniProtKB:P00747}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Note=Locates to the cell
CC       surface where it is proteolytically cleaved to produce the active
CC       plasmin. Interaction with HRG tethers it to the cell surface (By
CC       similarity). {ECO:0000250}.
CC   -!- DOMAIN: Kringle domains mediate interaction with CSPG4. {ECO:0000250}.
CC   -!- PTM: In the presence of the inhibitor, the activation involves only
CC       cleavage after Arg-581, yielding two chains held together by two
CC       disulfide bonds. In the absence of the inhibitor, the activation
CC       involves additionally the removal of the activation peptide (By
CC       similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Plasmin is inactivated by alpha-2-antiplasmin
CC       immediately after dissociation from the clot.
CC   -!- MISCELLANEOUS: In the presence of the inhibitor, the activation
CC       involves only cleavage after Arg-581, resulting in 2 chains held
CC       together by 2 disulfide bonds. Without the inhibitor, the activation
CC       involves also removal of the activation peptide (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. Plasminogen subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ242649; CAB46014.1; -; mRNA.
DR   EMBL; BC091135; AAH91135.1; -; mRNA.
DR   EMBL; M62832; AAA41884.1; -; mRNA.
DR   PIR; A40522; A40522.
DR   RefSeq; NP_445943.1; NM_053491.2.
DR   AlphaFoldDB; Q01177; -.
DR   SMR; Q01177; -.
DR   BioGRID; 250057; 1.
DR   IntAct; Q01177; 1.
DR   STRING; 10116.ENSRNOP00000023370; -.
DR   BindingDB; Q01177; -.
DR   ChEMBL; CHEMBL3204; -.
DR   DrugCentral; Q01177; -.
DR   MEROPS; S01.233; -.
DR   PhosphoSitePlus; Q01177; -.
DR   SwissPalm; Q01177; -.
DR   PaxDb; 10116-ENSRNOP00000023370; -.
DR   Ensembl; ENSRNOT00000023368.6; ENSRNOP00000023370.3; ENSRNOG00000017223.8.
DR   Ensembl; ENSRNOT00055048697; ENSRNOP00055040019; ENSRNOG00055027842.
DR   Ensembl; ENSRNOT00060016838; ENSRNOP00060013160; ENSRNOG00060009885.
DR   Ensembl; ENSRNOT00065050859; ENSRNOP00065041809; ENSRNOG00065029290.
DR   GeneID; 85253; -.
DR   KEGG; rno:85253; -.
DR   AGR; RGD:619893; -.
DR   CTD; 5340; -.
DR   RGD; 619893; Plg.
DR   eggNOG; ENOG502QVNP; Eukaryota.
DR   GeneTree; ENSGT00940000155208; -.
DR   HOGENOM; CLU_017565_0_0_1; -.
DR   InParanoid; Q01177; -.
DR   OrthoDB; 211181at2759; -.
DR   PhylomeDB; Q01177; -.
DR   TreeFam; TF329901; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-1592389; Activation of Matrix Metalloproteinases.
DR   Reactome; R-RNO-186797; Signaling by PDGF.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-75205; Dissolution of Fibrin Clot.
DR   PRO; PR:Q01177; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000017223; Expressed in liver and 16 other cell types or tissues.
DR   ExpressionAtlas; Q01177; baseline and differential.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:CAFA.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0034185; F:apolipoprotein binding; ISO:RGD.
DR   GO; GO:0004175; F:endopeptidase activity; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:CAFA.
DR   GO; GO:0019900; F:kinase binding; ISO:RGD.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:1990405; F:protein antigen binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0051087; F:protein-folding chaperone binding; ISO:RGD.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0007596; P:blood coagulation; ISO:RGD.
DR   GO; GO:0022617; P:extracellular matrix disassembly; ISO:RGD.
DR   GO; GO:0042730; P:fibrinolysis; ISO:RGD.
DR   GO; GO:0060716; P:labyrinthine layer blood vessel development; ISO:RGD.
DR   GO; GO:0071674; P:mononuclear cell migration; ISO:RGD.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; ISO:RGD.
DR   GO; GO:0045445; P:myoblast differentiation; ISO:RGD.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; ISO:RGD.
DR   GO; GO:0051918; P:negative regulation of fibrinolysis; ISO:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0051919; P:positive regulation of fibrinolysis; ISO:RGD.
DR   GO; GO:0006508; P:proteolysis; ISO:RGD.
DR   GO; GO:0051603; P:proteolysis involved in protein catabolic process; IDA:RGD.
DR   GO; GO:0042246; P:tissue regeneration; ISO:RGD.
DR   GO; GO:0048771; P:tissue remodeling; IEA:UniProtKB-KW.
DR   GO; GO:0099183; P:trans-synaptic signaling by BDNF, modulating synaptic transmission; ISO:RGD.
DR   GO; GO:0060707; P:trophoblast giant cell differentiation; ISO:RGD.
DR   CDD; cd00108; KR; 5.
DR   CDD; cd01099; PAN_AP_HGF; 1.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 3.50.4.10; Hepatocyte Growth Factor; 1.
DR   Gene3D; 2.40.20.10; Plasminogen Kringle 4; 4.
DR   Gene3D; 2.40.10.10; Trypsin-like serine proteases; 1.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR038178; Kringle_sf.
DR   InterPro; IPR003609; Pan_app.
DR   InterPro; IPR023317; Pept_S1A_plasmin.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR050759; Serine_protease_kringle.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   PANTHER; PTHR24261:SF13; PLASMINOGEN; 1.
DR   PANTHER; PTHR24261; PLASMINOGEN-RELATED; 1.
DR   Pfam; PF00051; Kringle; 5.
DR   Pfam; PF00024; PAN_1; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PIRSF; PIRSF001150; Plasmin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   PRINTS; PR00018; KRINGLE.
DR   SMART; SM00130; KR; 5.
DR   SMART; SM00473; PAN_AP; 1.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF57414; Hairpin loop containing domain-like; 1.
DR   SUPFAM; SSF57440; Kringle-like; 5.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS00021; KRINGLE_1; 5.
DR   PROSITE; PS50070; KRINGLE_2; 5.
DR   PROSITE; PS50948; PAN; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   2: Evidence at transcript level;
KW   Blood coagulation; Cleavage on pair of basic residues; Disulfide bond;
KW   Fibrinolysis; Hemostasis; Hydrolase; Kringle; Phosphoprotein; Protease;
KW   Reference proteome; Repeat; Secreted; Serine protease; Signal;
KW   Tissue remodeling; Zymogen.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000250"
FT   CHAIN           20..812
FT                   /note="Plasminogen"
FT                   /id="PRO_0000028079"
FT   CHAIN           20..581
FT                   /note="Plasmin heavy chain A"
FT                   /id="PRO_0000028080"
FT   PEPTIDE         20..97
FT                   /note="Activation peptide"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000028081"
FT   CHAIN           98..581
FT                   /note="Plasmin heavy chain A, short form"
FT                   /id="PRO_0000028082"
FT   CHAIN           98..?436
FT                   /note="Angiostatin"
FT                   /id="PRO_0000028083"
FT   CHAIN           582..812
FT                   /note="Plasmin light chain B"
FT                   /id="PRO_0000028084"
FT   DOMAIN          20..98
FT                   /note="PAN"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00315"
FT   DOMAIN          102..181
FT                   /note="Kringle 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   DOMAIN          184..262
FT                   /note="Kringle 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   DOMAIN          274..352
FT                   /note="Kringle 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   DOMAIN          375..454
FT                   /note="Kringle 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   DOMAIN          480..560
FT                   /note="Kringle 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   DOMAIN          582..810
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   ACT_SITE        624
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        667
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        762
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         598
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P00747"
FT   MOD_RES         690
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P00747"
FT   DISULFID        49..73
FT                   /evidence="ECO:0000250"
FT   DISULFID        53..61
FT                   /evidence="ECO:0000250"
FT   DISULFID        103..181
FT                   /evidence="ECO:0000250"
FT   DISULFID        124..164
FT                   /evidence="ECO:0000250"
FT   DISULFID        152..176
FT                   /evidence="ECO:0000250"
FT   DISULFID        185..262
FT                   /evidence="ECO:0000250"
FT   DISULFID        188..316
FT                   /evidence="ECO:0000250"
FT   DISULFID        206..245
FT                   /evidence="ECO:0000250"
FT   DISULFID        234..257
FT                   /evidence="ECO:0000250"
FT   DISULFID        275..352
FT                   /evidence="ECO:0000250"
FT   DISULFID        296..335
FT                   /evidence="ECO:0000250"
FT   DISULFID        324..347
FT                   /evidence="ECO:0000250"
FT   DISULFID        376..454
FT                   /evidence="ECO:0000250"
FT   DISULFID        397..437
FT                   /evidence="ECO:0000250"
FT   DISULFID        425..449
FT                   /evidence="ECO:0000250"
FT   DISULFID        481..560
FT                   /evidence="ECO:0000250"
FT   DISULFID        502..543
FT                   /evidence="ECO:0000250"
FT   DISULFID        531..555
FT                   /evidence="ECO:0000250"
FT   DISULFID        568..687
FT                   /note="Interchain (between A and B chains)"
FT                   /evidence="ECO:0000250"
FT   DISULFID        578..586
FT                   /note="Interchain (between A and B chains)"
FT                   /evidence="ECO:0000250"
FT   DISULFID        609..625
FT                   /evidence="ECO:0000250"
FT   DISULFID        701..768
FT                   /evidence="ECO:0000250"
FT   DISULFID        731..747
FT                   /evidence="ECO:0000250"
FT   DISULFID        758..786
FT                   /evidence="ECO:0000250"
FT   CONFLICT        418
FT                   /note="A -> S (in Ref. 3; AAA41884)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   812 AA;  90536 MW;  8C703C51410EBC9E CRC64;
     MDHKEIILLF LLFLKPGQGD SLDGYVSTQG ASLHSLTKKQ LAAGSIADCL AKCEGETDFI
     CRSFQYHSKE QQCVIMAENS KTSSIIRMRD VILFEKRVYL SECKTGIGKG YRGTMSKTKT
     GVTCQKWSDT SPHVPKYSPS THPSEGLEEN YCRNPDNDEQ GPWCYTTDPD QRYEYCNIPE
     CEEECMYCSG EKYEGKISKT MSGLDCQSWD SQSPHAHGYI PAKFPSKNLK MNYCRNPDGE
     PRPWCFTTDP NKRWEYCDIP RCTTPPPPPG PTYQCLKGRG ENYRGTVSVT ASGKTCQRWS
     EQTPHRHNRT PENFPCKNLE ENYCRNPDGE TAPWCYTTDS QLRWEYCEIP SCGSSVSPDQ
     SDSSVLPEQT PVVQECYQGN GKSYRGTSST TNTGKKCQSW VSMTPHSHSK TPANFPDAGL
     EMNYCRNPDN DQRGPWCFTT DPSVRWEYCN LKRCSETGGG VAESAIVPQV PSAPGTSETD
     CMYGNGKEYR GKTAVTAAGT PCQEWAAQEP HSHRIFTPQT NPRAGLEKNY CRNPDGDVNG
     PWCYTMNPRK LYDYCNIPLC ASLSSFECGK PQVEPKKCPG RVVGGCVANP HSWPWQISLR
     TRFSGQHFCG GTLISPEWVL TAAHCLEKSS RPEFYKVILG AHEERILGSD VQQIAVTKLV
     LEPNDADIAL LKLSRPATIT DNVIPACLPS PNYVVADRTL CYITGWGETK GTPGAGRLKE
     AQLPVIENKV CNRAEYLNNR VKSTELCAGH LAGGIDSCQG DSGGPLVCFE KDKYILQGVT
     SWGLGCARPN KPGVYVRVSR YVNWIEREMR ND
//
